Understanding Hemiparkinsonism-Hemiatrophy Syndrome (HPHA)
At a Glance
Hemiparkinsonism-hemiatrophy syndrome (HPHA) is a rare condition in which Parkinson-like slowness, stiffness, or tremor affects one side of the body along with smaller or asymmetric body structures. MRI findings and progression vary, so diagnosis and care are individualized.
Hemiparkinsonism-Hemiatrophy Syndrome (HPHA) is a rare condition where a person develops signs of Parkinson’s disease (parkinsonism) on one side of the body, which is also the same side that shows some degree of wasting, smaller size, or asymmetry (hemiatrophy) [1][2]. This is an unusual finding because, in typical Parkinson’s disease, the brain may appear normal on a standard MRI early on, and visible structural hemiatrophy of the limbs or body is not a defining feature [3].
Because HPHA is so rare, there are no large-scale studies to tell us exactly how many people have it; most of what we know comes from small groups of patients or individual case reports [4][2]. If you have been diagnosed with HPHA, it is natural to feel overwhelmed or uncertain. You are dealing with a rare diagnosis—one where standard, “one-size-fits-all” treatment guidelines do not yet exist.
Defining the “Two Halves” of HPHA
To understand HPHA, it helps to break the name down into its two components:
- Hemiparkinsonism: This refers to symptoms of Parkinson’s—such as bradykinesia (slowness of movement), rigidity (muscle stiffness), and sometimes a resting tremor—that primarily affect one side of the body [2][3].
- Hemiatrophy: This means that one side of the body (or part of it) is structurally smaller or underdeveloped compared to the other. This can involve a limb, the face, or even the trunk [4]. In many cases, an MRI also shows that one side of the brain (cerebral hemiatrophy) is smaller than the other [5].
Usually, the side of the brain that shows structural differences is opposite the side of the body with symptoms. For example, if you have right-sided body symptoms, the left side of your brain may show the asymmetry [2][5].
Why Does This Happen?
Scientists are still working to understand the causes of HPHA. It is likely not a single disease, but a “phenotype”—a set of symptoms that can be caused by different underlying issues. Current hypotheses include:
- Early Brain Injury: This is one proposed theory based on case reports. It suggests that a subtle injury occurred very early in life—perhaps during birth or early childhood—due to a lack of oxygen (hypoxia), a small stroke, or head trauma [4][3]. This may leave you with a lower “nigrostriatal reserve”—essentially, fewer functional dopamine pathways on one side [3].
- The “Double Hit” Hypothesis: Some researchers have hypothesized that an early injury “primes” the brain, and then as you age or if you develop a secondary neurodegenerative process, the symptoms appear first on the weakened side [3]. This is strictly a research hypothesis and is not established for most patients.
- Atypical Development: In some cases, the asymmetry might be developmental, meaning the brain and body simply grew unevenly from the start [6].
How HPHA Differs from Typical Parkinson’s
While the symptoms look like Parkinson’s, the clinical pattern can differ. This leads to several comparisons, though these are patterns, not absolute rules:
| Feature | Typical Parkinson’s | HPHA |
|---|---|---|
| Symmetry | Usually starts on one side and often spreads to the other, though it can remain asymmetric for years. | Often remains strictly or predominantly on one side, sometimes for many years, though progression can occur [4][3]. |
| Physical Build | Visible structural hemiatrophy is not a defining feature, though reduced use can affect muscle bulk. | One side of the body or face is noticeably smaller or structurally asymmetric (hemiatrophy) [1]. |
| MRI Findings | Standard structural MRI typically does not show pronounced focal atrophy early on. | May show structural differences or old injury marks on one side of the brain, though scans can also be normal [5]. |
| Levodopa Response | Generally responds well initially, though not all symptoms improve. | Response is unpredictable; some patients find it very helpful, while others see little benefit [2][3]. |
Common Challenges and Misunderstandings
Because it is so rare, you may have encountered several hurdles on your way to a diagnosis:
- Misdiagnosis: In its early stages, HPHA can be mistaken for Young-Onset Parkinson’s Disease (if you are younger) or even a form of Cerebral Palsy (if the body asymmetry was noticed early in life) [7][3].
- Variable Progression: Some people with HPHA experience very slow progression, with symptoms staying on one side for decades. Others may eventually see symptoms spread to the other side [4][3].
- Diagnostic Uncertainty: You may find that different tests (like a DaTscan, which measures dopamine-transporter binding) show different results. An abnormal DaTscan does not definitively confirm HPHA, and a normal scan does not rule it out [2][4].
Navigating a Rare Diagnosis
It is important to remember that because HPHA is heterogeneous—meaning it looks different in every person—your care must be highly personalized. There is no “standard” progression path. Some people find that their symptoms remain mild and stable for a long time, while others require more active management of stiffness or tremor [4].
Validating your experience is key: it is harder to find support groups or clear answers when your condition doesn’t fit the standard mold. Working with a movement disorder specialist—a neurologist who has specific training in rare parkinsonian syndromes—is the best way to ensure your treatment is tailored to your specific symptoms and imaging findings [1][5].
Common questions in this guide
What is hemiparkinsonism-hemiatrophy syndrome?
What symptoms can HPHA cause?
How is HPHA different from typical Parkinson’s disease?
Can an MRI or DaTscan confirm HPHA?
What causes hemiparkinsonism-hemiatrophy syndrome?
Will HPHA spread to the other side of my body?
Does levodopa help people with HPHA?
Get notified when new evidence is published on Hemiparkinsonism-hemiatrophy syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (7)
- 1
Hemiparkinsonism-hemiatrophy syndrome.
Ayromlou H, Najmi S, Arami MA
Archives of Iranian medicine 2011; (14(2)):152-4 doi:011142/AIM.0017.
PMID: 21361726 - 2
Subcortical and brainstem hemiatrophy accompanied by iron deposition in a patient with hemiparkinsonism-hemiatrophy syndrome: a case report.
Chung SJ
BMC neurology 2021; (21(1)):51 doi:10.1186/s12883-021-02080-4.
PMID: 33535984 - 3
Neuropathologic findings in a patient with hemiparkinsonism and hemiatrophy syndrome.
Nakamura M, Tsuge A, Miyake K, et al.
Neuropathology : official journal of the Japanese Society of Neuropathology 2024; (44(6)):432-439 doi:10.1111/neup.12994.
PMID: 38972833 - 4
Hemiparkinsonism or Hemidystonia With Hemiatrophy Syndrome: A Case Series With Follow-Up.
He C, Zhang P, Li Y, et al.
Frontiers in neuroscience 2020; (14()):64 doi:10.3389/fnins.2020.00064.
PMID: 32116511 - 5
[Hemiparkinsonism-Hemiatrophy Syndrome with Hypoperfusion in Basal Ganglia: A Case Report].
Ma B, Wang LH, Zhang YN
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 2021; (52(3)):531-533 doi:10.12182/20210560106.
PMID: 34018377 - 6
Anterograde Degeneration of the Nigrostriatal Pathway Visualized by 123I-FP-CIT SPECT in a Patient With Artery of Percheron Infarction.
Nakadate M, Miyamoto N, Starkey J, et al.
Clinical nuclear medicine 2016; (41(6)):483-4 doi:10.1097/RLU.0000000000001187.
PMID: 26914571 - 7
A rare case of Dyke-Davidoff-Masson syndrome with concurrent metabolic syndrome.
Rameshbabu S, Nallathambi N, Shaaruk D, et al.
Radiology case reports 2025; (20(9)):4844-4848 doi:10.1016/j.radcr.2025.06.017.
PMID: 40686799
This page is for informational purposes only and does not constitute medical advice. A movement disorder neurologist should interpret your symptoms and imaging and discuss testing and treatment for your specific situation.